Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals financial challenges, including a net loss and cash flow concerns, despite revenue growth. The company's investments in new ventures and initiatives like MicroCo carry significant uncertainty and risk. The Q&A highlighted management's lack of clarity on key strategic initiatives, which may raise investor concerns. While there are positive aspects, such as streaming growth and direct advertising success, the overall sentiment leans negative due to financial strain and uncertainty around new ventures.
Revenue $11.1 million, a $2.0 million or 22% increase over the prior year quarter. The increase was attributed to strong performance across key business lines.
Gross Margin 57%, compared to 51% last year. This was materially above the guidance of 45% to 50%, driven by strong revenue growth.
Net Loss $3.5 million, compared to $3.1 million in the prior year quarter. The decline was primarily due to increased SG&A expenses for sales, legal, marketing, and technology investments.
Adjusted EBITDA Negative $2.1 million, compared to $1.4 million in the prior year quarter. The decline was attributed to increased SG&A expenses to support expanding theatrical and technology initiatives.
Cash and Cash Equivalents $2 million as of June 30, 2025, with $8.9 million available on a $12.5 million working capital facility. The decline in cash was due to content acquisition and royalty payments, primarily related to Terrifier 3.
Streaming Metrics 4 billion total minutes viewed, up 38% year-over-year and 20% sequentially. FAST minutes streamed were 3.8 billion, a 39% increase over the prior year. Total streaming viewers climbed to 214 million, up 24%. Subscriber count grew to 1.4 million, an increase of 5% year-over-year and 1% over the prior quarter.
Direct Advertising Business Grew 57% year-over-year, driven by new and returning advertisers.
The Toxic Avenger Unrated: Scheduled for release on August 29, 2025, with a favorable risk-reward profile due to low investment costs (less than $5 million) and complete ownership of North American rights.
Air Bud Returns: Acquired for a wide release revival in late summer 2026, leveraging its built-in audience and positive media reception.
MicroCo: A new joint venture targeting the $10 billion microseries market by 2027, aiming to create a Netflix-like platform for microseries with a strong leadership team and leveraging Cineverse's technology and AI assets.
Streaming Growth: Achieved 4 billion total minutes viewed, a 38% year-over-year increase, and 214 million total streaming viewers, up 24%.
Advertising Growth: Direct advertising business grew 57% year-over-year, with strong adoption of the proprietary C360 ad platform.
Revenue and Margins: Reported $11.1 million in revenue, a 22% increase year-over-year, and a gross margin of 57%, up from 51% last year.
SG&A Investments: Increased investments in sales, marketing, and technology to support theatrical and technology initiatives, expected to yield strong returns in the fiscal year.
Theatrical Expansion: Building a slate of 14 wide and limited theatrical releases per year, targeting highly engaged fandoms and leveraging internal media assets.
Microseries Platform: Strategic entry into the microseries market with a focus on cost-effective, high-quality content and leveraging Cineverse's unique assets.
SG&A and Marketing Investments: Increased investments in SG&A and marketing to support expanding theatrical releasing business and technology initiatives have negatively impacted adjusted EBITDA and net income. The company expects returns from these investments in the future, but they currently pose a financial strain.
Cash Flow and Liquidity: The company reported a decline in cash due to content acquisition and royalty payments, with only $2 million in cash and cash equivalents as of June 30, 2025. This could pose liquidity challenges despite having $8.9 million available on a working capital facility.
Advertising Revenue: Headwinds from open market programmatic advertising have impacted advertising revenue, though direct business has shown growth. This mixed performance could affect overall revenue stability.
Economic Viability of Theatrical Releases: While the company emphasizes a favorable risk-reward profile for its theatrical releases, the ultimate success of these films depends on achieving box office breakeven and beyond, which remains uncertain.
Dependence on New Ventures: The company is heavily investing in new ventures like MicroCo and expanding into microseries, which are unproven markets. The success of these initiatives is uncertain and could pose financial and operational risks.
Regulatory and Competitive Pressures: The company operates in a highly competitive and regulated industry, which could impact its ability to execute its strategic objectives effectively.
Revenue and Margin Projections: The company expects strong top and bottom-line results for the remainder of the fiscal year, driven by upfront investments in SG&A, marketing, and technology. Gross margin guidance for the quarter was materially exceeded at 57%, compared to the expected 45%-50%.
Streaming Business Growth: The company anticipates aggressive growth in streaming over the next two quarters through new partnerships, bundling strategies, and marketing execution. Subscriber count and streaming minutes are expected to continue increasing.
Advertising Recovery: Signs of recovery in advertising are expected as brands and agencies restore spending in the back half of the year. Direct advertising business is growing strongly, with a 57% year-over-year increase.
MicroCo Joint Venture: The company projects the Microseries market to reach $10 billion by 2027 and aims to establish MicroCo as a leading platform in this space. Investments in technology, AI, and content are expected to provide a competitive advantage.
Theatrical Releases and IP Strategy: The company plans to expand its theatrical slate to 14 pictures per year over the next several years, focusing on wide releases with favorable risk-reward profiles and leveraging known IPs. Upcoming releases include 'The Toxic Avenger,' 'Silent Night, Deadly Night,' and 'Air Bud Returns.'
Market Trends and Strategic Positioning: The company is leveraging its unique assets to disrupt traditional Hollywood studio economics and create competitive advantages in emerging markets like Microseries and theatrical releases.
The selected topic was not discussed during the call.
The earnings call highlights several challenges: a 3% revenue decline, increased SG&A expenses leading to a net loss, and liquidity concerns with only $2.3 million in cash. The box office underperformance and competitive pressures in technology and micro drama ventures add to the negative sentiment. Despite some positives like streaming growth and improved margins, the overall outlook is clouded by financial and strategic uncertainties, leading to a likely negative stock price reaction.
The earnings call reveals financial challenges, including a net loss and cash flow concerns, despite revenue growth. The company's investments in new ventures and initiatives like MicroCo carry significant uncertainty and risk. The Q&A highlighted management's lack of clarity on key strategic initiatives, which may raise investor concerns. While there are positive aspects, such as streaming growth and direct advertising success, the overall sentiment leans negative due to financial strain and uncertainty around new ventures.
The earnings call summary reveals strong financial performance, with significant revenue growth and improved margins. The company is expanding into new content areas and has a promising pipeline for cineSearch and Matchpoint. However, some uncertainties remain, such as regulatory challenges and operational transitions. The Q&A section indicates management's confidence in margin targets and growth potential, despite avoiding specific timelines. Overall, the positive financial results and strategic initiatives outweigh the risks, suggesting a positive stock price movement.
Cineverse's earnings call revealed strong financial performance, with a 207% revenue increase and zero debt, indicating financial stability. The partnership with Google and AI integration are strategic positives, while cost-cutting measures enhance profitability. Despite vague responses in the Q&A, the company's optimistic guidance and strong revenue growth suggest a positive stock reaction. The lack of market cap data implies a neutral impact from size-related volatility. Overall, factors like strong earnings, strategic partnerships, and optimistic guidance outweigh any concerns, leading to a 'Positive' sentiment rating.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.